« Back to Record
Hortobagyi, G. N., Deleu, I., Shtivelband, M., Masuda, N., Dakhil, S., Anderson, I., Robinson, D. D., He, W., Garg, A., McDonald, R. E., Bitter, H., Chen, D., Huang, A., Taran, T., Bachelot, T., Lebrun, F., Lebwohl, D., Baselga, J., Piccart-Gebhart, M., Rugo, H., Burris, H. H., Pritchard, K., Campone, M., Noguchi, S., & Perez, A. (2016). Correlative analysis of genetic alterations and everolimus benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Results from BOLERO-2. Journal of clinical oncology, 34(5), 419-426. doi:10.1200/JCO.2014.60.1971
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231186



